Generic drugs cost 80-85% less than brand-name drugs because they don’t repeat expensive clinical trials. They’re chemically identical, FDA-approved, and just as effective - saving patients and the healthcare system billions every year.
Hospital formularies determine which generic drugs are available to patients, using clinical evidence, cost analysis, and safety data. Learn how P&T committees make these decisions-and why they matter more than you think.
Medicare Part D reforms in 2025 have slashed out-of-pocket costs for generic drugs, capping annual spending at $2,000. Learn how copays, plan types, and Extra Help work to save you money on prescriptions.
AI and pharmacogenomics are transforming online pharmacies by tailoring generic drug recommendations to your DNA. Learn how this tech works, who benefits, and what to watch out for in 2026.
Learn how to find the lowest cash prices for medications using discount apps, independent pharmacies, and mail-order services. Save up to 90% on generics without insurance.
Complex generics face major hurdles in proving bioequivalence due to their intricate formulations and local delivery mechanisms. Unlike simple pills, these drugs require advanced testing methods, regulatory alignment, and deep scientific understanding to ensure they work as well as the brand name.
Infographics about generics help patients understand that generic drugs are just as safe and effective as brand-name versions. Learn how visual tools are improving medication adherence, cutting costs, and building trust.
Pharmacists should recommend authorized generics for patients with inactive ingredient sensitivities, narrow therapeutic index drugs, or modified-release formulations. They offer brand-level safety at generic prices - but only if you know when and how to suggest them.
Contamination controls in generic drug manufacturing prevent harmful adulteration through strict cleanroom standards, real-time monitoring, and human process discipline - ensuring patient safety and regulatory compliance.
Evergreening lets drug companies extend patents on old medications with minor changes, blocking generics and keeping prices high. Learn how it works, who it hurts, and what’s being done to stop it.